[摘要]目的：观察氟哌噻吨美利曲辛片（黛力新）对慢性心力衰竭（CHF）

[Abstract] Objective: To observe flupentixol melitracen piece (Deanxit) effect on chronic heart failure (CHF) combined with anxiety anxiety, depression and quality of life of patients with depressive patients. Methods: The hospital in March 2017 - July 2019 admissions of 98 patients with CHF combined with anxiety depression were divided into groups according to the conventional treatment group and the lottery law, each of the 49 cases; conventional therapy group using conventional methods, in the conventional treatment group plus new treatment Deanxit by group basis. With Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) assessment of the two groups of patients with anxiety, depression degrees to heart failure Minnesota Quality of Life Scale (MLHFQ) assess the quality of life of patients in both groups before and after treatment. Results: Before treatment, the conventional SDS score and treatment groups, the SAS score, score MLHFQ no significant difference (all P> 0.05), after treatment, two sets of the scores were significantly decreased (P> 0.05) before treatment, and the score of the treatment group was significantly lower than group (P> 0.05). Conclusion: Deanxit of CHF combined with anxiety mental state and quality of life in patients with depression are significantly improved, with a certain clinical application and promotion value.

Objective: To observe the effects of fluorine tons of meriquine tablets (Delixin) on anxiety, depression and quality of life in patients with chronic heart failure (CHF) combined with anxiety and depression. Methods: 98 CHF combined anxiety and depression patients who received treatment from March 2017 to July 2019 were divided into regular groups and treatment groups according to the drawing method, each with 49 cases; The Anxiety Self-Assessment Scale (SAS) and The Depression Self-Assessment Scale (SDS) assessed the anxiety and depression of both groups before and after treatment, and the quality of life of both groups of patients was assessed on the Minnesota Heart Insufficiency Quality Scale (MLHFQ). Results: Prior to treatment, there was no significant difference between the sDS score, SAS score, and MLHFQ score of the general group and the treatment group (both p.05), and after treatment, the above-mentioned scores were significantly lower than before treatment (both P.05), and the treatment group scored significantly lower than the regular group (average P.05). Conclusion: Delixin has significant effect on the improvement of psychological state and quality of life in patients with CHF combined anxiety and depression, and has certain clinical application and promotion value.

[Abstract] Objective: To observe the effect of droperidol and melitracen on anxiety, depression and quality of life in patients with chronic heart failure (CHF) complicated with anxiety and depression. Methods: 98 CHF patients with anxiety and depression who received treatment in our hospital from March 2017 to July 2019 were divided into the conventional group and the treatment group according to the method of drawing lots, 49 cases in each group; the conventional group was treated with the conventional method, and the treatment group was treated with Deanxit on the basis of the conventional group. SAS and SDS were used to evaluate the anxiety and depression of the two groups before and after treatment, and mlhfq was used to evaluate the quality of life of the two groups. Results: before treatment, there was no significant difference in SDS score, SAS score and mlhfq score between the conventional group and the treatment group (all P > 0.05). After treatment, the above scores in the two groups were significantly lower than those before treatment (all P > 0.05), and the scores in the treatment group were significantly lower than those in the conventional group (all P > 0.05). Conclusion: Deanxit can improve the mental state and quality of life of CHF patients with anxiety and depression significantly, which has certain clinical application and promotion value.